Black Seed Oil Cholesterol Meta-analysis: What the Evidence Says

Quick Answer

Black Seed Oil Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Additionally, the risk of disease development is significantly increased by comorbidities such as obesity, type 2 diabetes, and metabolic syndrome. [Fic Weronika (2026); evidence level 3]
• Excessive enlargement of the necrotic core relative to the thickness of the fibrous cap increases the risk of plaque rupture and thrombus formation. [Fic Weronika (2026); evidence level 3]
• Dietary approaches are considered a key component in the prevention and management of cardiometabolic risk factors. [Kuo Wu-Hsien (2026); evidence level 4]
• In addition to its effects on traditional cardiometabolic risk factors, emerging findings from animal and cellular models suggest that sesame supplementation may exert biological effects relevant to retinopathy, a common microvascular complication of metabolic disorders, particularly diabetes,. [Kuo Wu-Hsien (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For black seed oil cholesterol meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Fic Weronika (2026). Thymoquinone in Atherosclerosis: A Multi-Target Nutraceutical Modulating Inflammation, Oxidative Stress, and Lipid Metabolism. DOI: 10.3390/nu18091480. PMCID: PMC13165017. PMID: 42124081. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165017/
• Kuo Wu-Hsien (2026). Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. DOI: 10.7150/ijms.123717. PMCID: PMC12964580. PMID: 41799776. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12964580/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.